Dear JITC Readers,
The JITC Reading List will no longer be updated. Over the years, we have shared key scientific articles to help researchers, clinicians, and professionals stay informed on the latest advancements in cancer immunotherapy. We appreciate the support of our readers and contributors who have made this initiative a valuable resource for the scientific community.
While this initiative has concluded, you can continue to explore the latest research by visiting jitc.bmj.com, where new articles and studies are regularly published.